Compass Pathways PLC (CMPS)
7.89
-0.10
(-1.25%)
USD |
NASDAQ |
May 17, 16:00
7.79
-0.10
(-1.27%)
After-Hours: 20:00
Compass Pathways Total Assets (Quarterly): 308.99M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 308.99M |
| December 31, 2023 | 275.99M |
| September 30, 2023 | 299.03M |
| June 30, 2023 | 209.83M |
| March 31, 2023 | 173.31M |
| December 31, 2022 | 197.29M |
| September 30, 2022 | 224.52M |
| June 30, 2022 | 238.64M |
| March 31, 2022 | 272.10M |
| Date | Value |
|---|---|
| December 31, 2021 | 300.90M |
| September 30, 2021 | 314.74M |
| June 30, 2021 | 335.16M |
| March 31, 2021 | 196.14M |
| December 31, 2020 | 203.46M |
| September 30, 2020 | 208.00M |
| June 30, 2020 | 77.08M |
| December 31, 2019 | 32.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
32.39M
Minimum
Dec 2019
335.16M
Maximum
Jun 2021
227.50M
Average
224.52M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 35.43M |
| Autolus Therapeutics PLC | 375.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.83M |
| Shareholders Equity (Quarterly) | 259.16M |